Global Aneurysm Treatment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Aneurysm Treatment Market Analysis

The aneurysm treatment market has witnessed significant advancements, driven by increasing awareness, technological innovation, and the growing prevalence of aneurysms worldwide. An aneurysm, a localized blood vessel dilation, often poses life-threatening risks if left untreated, particularly when it occurs in critical areas such as the brain or aorta. The market has expanded due to rising incidences of hypertension, lifestyle-related stress, and an aging population that is more susceptible to vascular conditions. Technological advancements have revolutionized the diagnosis and treatment of aneurysms. Innovations such as minimally invasive endovascular procedures, advanced embolization devices, and flow-diverting stents have improved patient outcomes by offering safer and more effective options. For instance, AI integration, as seen in tools such as PreSize, enhances precision in stent placement, reducing procedural risks. Moreover, companies such as Stryker and Medtronic continue to invest in cutting-edge technologies, including pipeline embolization devices and intrasaccular flow-diverting systems. Geographically, North America dominates the market due to robust healthcare infrastructure and high adoption of advanced therapies, while Asia-Pacific shows promising growth, driven by a rising geriatric population and increasing healthcare investments. The market's future hinges on continued R&D, enhancing treatment accessibility, and addressing high treatment costs to ensure broader adoption globally.

Aneurysm Treatment Market Size

The global aneurysm treatment market size was valued at USD 5.97 billion in 2024 and is projected to reach USD 10.45 billion by 2032, with a CAGR of 7.24% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Aneurysm Treatment Market Trends

“Growing Adoption of Minimally Invasive Endovascular Procedures”

One significant trend in the aneurysm treatment market is the growing adoption of minimally invasive endovascular procedures, which offer safer and more efficient alternatives to traditional open surgeries. These procedures, such as endovascular coiling and the use of flow-diverting stents, are increasingly preferred due to reduced recovery times and lower procedural risks. For instance, the WEB Aneurysm Embolization System by MicroVention has gained prominence as one of the most studied intrasaccular devices, with five-year follow-up data validating its efficacy and safety. Additionally, technological advancements such as AI-assisted tools, such as PreSize, enhance precision in treatment planning, further driving the adoption of these innovations. This trend is particularly strong in regions such as North America and Europe, where robust healthcare infrastructure supports the use of advanced medical technologies. As healthcare providers and patients continue to prioritize minimally invasive options, this trend is expected to propel the growth of the aneurysm treatment market in the coming years.

Report Scope and Aneurysm Treatment Market Segmentation         

Aneurysm Treatment Market Definition

Aneurysm treatment refers to the medical interventions and procedures used to manage and repair aneurysms, which are abnormal bulges or ballooning in the wall of a blood vessel. These treatments aim to prevent rupture, reduce symptoms, and improve patient outcomes. Options include medication to control underlying conditions such as hypertension, surgical procedures such as clipping, and minimally invasive surgical techniques such as endovascular coiling or the use of flow-diverting stents. Advanced technologies, including embolization devices and imaging-guided interventions, have significantly enhanced the safety and effectiveness of aneurysm treatments.

Aneurysm Treatment Market Dynamics

Drivers

• Increasing Prevalence of Aneurysms

The rising prevalence of aneurysms, especially cerebral and aortic aneurysms, is a significant driver of the aneurysm treatment market. For instance, in the U.S., studies have shown that around 2-5% of the population may have an unruptured brain aneurysm, with an estimated 30,000 new cases of ruptured brain aneurysms occurring each year. Additionally, the prevalence of aortic aneurysms has been rising, with nearly 200,000 cases diagnosed annually in the U.S. alone, often linked to risk factors such as hypertension and smoking. These conditions contribute to the increasing demand for effective treatment solutions, such as endovascular coiling, flow-diverting stents, and advanced embolization devices. As the aging population also becomes more susceptible to these life-threatening conditions, the market for aneurysm treatment continues to grow, with increased healthcare investments, technological advancements, and a focus on early diagnosis and intervention helping to meet this rising demand. This growing prevalence of aneurysms is a critical driver for the market's expansion.

• Growing Geriatric Population

The growing geriatric population is a key driver of the aneurysm treatment market, as older individuals are more prone to developing aneurysms and related vascular conditions due to the natural weakening of blood vessel walls with age. In the U.S., the incidence of aortic aneurysms increases significantly after the age of 65, with studies indicating that approximately 10% of individuals over 65 may be affected by this condition. Similarly, the risk of cerebral aneurysms also rises with age, with a higher prevalence found in individuals over 50 years old. As the global population continues to age, with projections indicating that by 2030, over 1.4 billion people worldwide will be aged 60 or older, the demand for advanced diagnostic tools and aneurysm treatment options, such as minimally invasive endovascular techniques and flow-diverting stents, is expected to increase. This demographic shift drives the market for aneurysm treatments, as healthcare systems must adapt to meet the needs of an aging population at higher risk for these conditions.

Opportunities

• Growing Technological Advancements in Aneurysm Treatment

Technological advancements in aneurysm treatment are playing a pivotal role in driving market growth, offering more precise, effective, and minimally invasive solutions. For instance, advanced embolization devices such as the WEB Aneurysm Embolization System and Pipeline Embolization Device have revolutionized the cerebral aneurysms treatment by improving safety and reducing recovery time compared to traditional open surgery. Additionally, the integration of AI-assisted tools, such as PreSize software, is enhancing the accuracy of stent placement in endovascular procedures, leading to better patient outcomes and fewer complications. These innovations reduce procedural risks and streamline the treatment process, making aneurysm management more accessible and efficient. As healthcare systems globally adopt these cutting-edge technologies, they present significant market opportunities, creating a demand for new and improved products. The continuous development of such technologies, coupled with growing awareness and patient preference for less invasive treatments, positions these advancements as key drivers of the aneurysm treatment market's expansion.

• Increasing Healthcare Expenditure

Increasing healthcare expenditure, particularly in developed regions, is a major driver of the aneurysm treatment market, as higher budgets enable the adoption of advanced medical technologies. For instance, the U.S. and European Union countries have consistently boosted healthcare spending, which facilitates the integration of cutting-edge treatments such as minimally invasive endovascular procedures, flow-diverting stents, and advanced embolic devices into clinical practice. The U.S. healthcare expenditure alone surpassed USD 4 trillion in recent years, with a significant portion allocated to cardiovascular and neurological diseases, including aneurysms. These investments allow hospitals and healthcare providers to acquire the latest technologies, improving patient outcomes and reducing treatment costs in the long run. As more countries follow suit and expand their healthcare budgets, especially in Asia-Pacific and Latin America, there is a growing market opportunity for companies that provide advanced aneurysm treatment solutions. This trend is expected to drive the widespread adoption of high-tech treatments, further propelling market growth.

Restraints/Challenges

• High Cost Involved in the Treatment and Diagnosis

High treatment costs pose a significant challenge in the aneurysm treatment market, as the financial burden associated with managing the condition can be substantial for both patients and healthcare systems. Treatments for aneurysms, especially in severe or ruptured cases, often require costly procedures such as endovascular aneurysm repair (EVAR) or open surgery, which involve the procedure itself and extended hospital stays, intensive care, and post-operative rehabilitation. Additionally, patients may require follow-up imaging, ongoing monitoring, and long-term care to manage the condition and prevent recurrence, all of which contribute to the overall expense. These high treatment costs create a financial barrier for many patients, particularly those without comprehensive health insurance coverage or in countries with limited healthcare resources. For healthcare systems, the expenses associated with aneurysm treatment can strain budgets, limiting the availability of advanced treatment options and causing delays in care. This economic burden also deters some patients from seeking timely treatment, increasing the risk of aneurysm rupture and potentially life-threatening complications. As a result, high treatment costs are a significant challenge that impacts patient access to care and hinders the growth of the aneurysm treatment market.

• Surgical Risks and Complications

Surgical risks and complications are a major challenge in the aneurysm treatment market, as the procedures used to treat aneurysms often carry significant risks. Surgical interventions, especially for complex aneurysms such as abdominal aortic or brain aneurysms, can result in serious complications such as infection, bleeding, organ damage, stroke, or even death. For instance, during aortic aneurysm repair, there is a risk of damage to surrounding organs or blood vessels, which can require additional surgeries and extend recovery time. Even minimally invasive procedures such as endovascular aneurysm repair (EVAR) carry risks such as graft migration, leakage, or endoleaks, where blood flows outside the graft, potentially leading to a rupture. These risks affect patient outcomes and influence the treatment decision-making process, as patients may hesitate to undergo surgery due to fear of complications. Furthermore, the need for highly skilled surgeons and specialized care for such high-risk procedures makes it difficult to ensure widespread access, particularly in underserved regions or healthcare settings with limited resources. Surgical risks and complications thus represent a significant barrier to the aneurysm treatment market, contributing to higher healthcare costs, longer recovery times, and lower patient compliance, all of which can limit the adoption of more advanced aneurysm treatments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Aneurysm Treatment Market Scope

The market is segmented on the basis of type, shape, treatment type, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Aortic Aneurysm
• Cerebral Aneurysm
• Others

Shape:

• Fusiform Aneurysms Bulge
• Saccular Aneurysms Bulge
• Others

Treatment Type

• Medication
• Surgery
• Others

Route of Administration

• Oral
• Injectable
• Others

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Aneurysm Treatment Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, shape, treatment type, route of administration, end-users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America holds a dominant position in the aneurysm treatment market, primarily driven by the growing geriatric population, which is more prone to aneurysms and related complications. Additionally, the rising prevalence of chronic conditions such as hypertension and stroke, both of which are significant risk factors for aneurysms, is further fueling the demand for effective treatment solutions in the region. Advancements in medical technology and increased access to healthcare facilities are also contributing to market growth. This trend is expected to continue during the forecast period, as awareness about aneurysm management and the availability of innovative treatment options expand across the region.

Asia-Pacific is expected to witness substantial growth in the aneurysm treatment market, driven by lifestyle-related stress factors and the rapid increase in the aging population, both of which contribute to a higher risk of aneurysms. Additionally, the rising prevalence of hypertension, a major risk factor for aneurysm development, is significantly boosting the demand for effective treatment options. Improved healthcare infrastructure and growing awareness of aneurysm-related conditions are further supporting market expansion. This growth trajectory is likely to continue in the coming years as the region invests in advanced medical technologies and preventive healthcare measures.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Aneurysm Treatment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Aneurysm Treatment Market Leaders Operating in the Market Are:

• Terumo Medical Corporation (Japan)
• Medtronic (Ireland)
• Novartis AG (Switzerland)
• Abbott (U.S.)
• Viatris Inc. (U.S.)
• InfraScan, Inc. (U.S.)
• MicroPort Scientific Corporation (China)
• Spiegelberg GmbH & Co. KG (Germany)
• WOCKHARDT (India)
• Pfizer Inc. (U.S.)
• Baxter (U.S.)
• AbbVie Inc. (U.S.)
• GLENMARK PHARMACEUTICALS LTD (India)
• Siemens (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• B. Braun SE (Germany)
• Smith + Nephew (U.K.)
• GSK plc (U.K.)

Latest Developments in Aneurysm Treatment Market

• In October 2023, a study published in the BMJ Journal of Neurointerventional Surgery revealed that PreSize, an AI software, outperformed human clinicians in predicting the placement of stents in patients' brains. This advancement highlights the potential of AI integration to create growth opportunities for companies in the neurointerventional market
• In July 2023, MicroVention, Inc., a subsidiary of Terumo Corporation, released the WEB-IT five-year follow-up data and introduced two new sizes to its WEB Aneurysm Embolization System. With seven Good Clinical Practice (GCP) studies and over 200 peer-reviewed publications, the WEB system is now the most extensively studied intrasaccular device available
• In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a medical device company specializing in neurointerventional products for intracranial aneurysms. This acquisition aims to enhance Stryker’s product portfolio for aneurysm treatment solutions
• In June 2022, the Indian subsidiary of Medtronic plc launched the Pipeline Vantage Embolization Device in India, a cutting-edge solution for the treatment of brain aneurysms
• In October 2021, Evasc Neurovascular introduced the third generation of its eCLIPs Bifurcation Flow Diverter, featuring a shapeable delivery wire, smaller size compatible with 0.021” and 0.027” ID microcatheters, and electrolytic detachment, making it more effective for treating intracranial bifurcation aneurysms

SKU-46585